Variant report
Variant | esv3387243 |
---|---|
Chromosome Location | chr5:69200496-69213094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:170)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr5:69202749-69202904 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr5:69204504-69204870 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr5:69204507-69204792 | GM12878 | blood: | n/a | n/a |
4 | BCL11A | chr5:69211028-69211228 | GM12878 | blood: | n/a | n/a |
5 | BCL11A | chr5:69212362-69212551 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr5:69209216-69209435 | GM12878 | blood: | n/a | n/a |
7 | BCL11A | chr5:69204540-69204785 | GM12878 | blood: | n/a | n/a |
8 | BCL11A | chr5:69204575-69204807 | GM12878 | blood: | n/a | n/a |
9 | CBX3 | chr5:69199893-69200723 | K562 | blood: | n/a | n/a |
10 | CEBPB | chr5:69199941-69200767 | K562 | blood: | n/a | n/a |
11 | CEBPB | chr5:69200373-69200614 | K562 | blood: | n/a | n/a |
12 | CEBPD | chr5:69200325-69200838 | K562 | blood: | n/a | n/a |
13 | CTCF | chr5:69205884-69206557 | K562 | blood: | n/a | n/a |
14 | CTCF | chr5:69200471-69200799 | K562 | blood: | n/a | n/a |
15 | CTCF | chr5:69200359-69200931 | K562 | blood: | n/a | n/a |
16 | CTCF | chr5:69205990-69206356 | K562 | blood: | n/a | n/a |
17 | CTCF | chr5:69209720-69209870 | BE2_C | brain: | n/a | n/a |
18 | CTCF | chr5:69200385-69200751 | K562 | blood: | n/a | n/a |
19 | CTCF | chr5:69206005-69206364 | K562 | blood: | n/a | n/a |
20 | EBF1 | chr5:69204501-69204868 | GM12878 | blood: | n/a | n/a |
21 | EBF1 | chr5:69209017-69209409 | GM12878 | blood: | n/a | n/a |
22 | EBF1 | chr5:69204506-69204879 | GM12878 | blood: | n/a | n/a |
23 | EP300 | chr5:69202674-69202981 | GM12878 | blood: | n/a | n/a |
24 | EP300 | chr5:69211012-69211339 | GM12878 | blood: | n/a | n/a |
25 | FOSL2 | chr5:69208910-69209215 | HepG2 | liver: | n/a | chr5:69209192-69209200 chr5:69209193-69209200 |
26 | FOSL2 | chr5:69206923-69207232 | HepG2 | liver: | n/a | n/a |
27 | FOSL2 | chr5:69211012-69211249 | HepG2 | liver: | n/a | n/a |
28 | FOSL2 | chr5:69208927-69209172 | HepG2 | liver: | n/a | n/a |
29 | FOSL2 | chr5:69209216-69209530 | HepG2 | liver: | n/a | n/a |
30 | FOSL2 | chr5:69201914-69202227 | HepG2 | liver: | n/a | n/a |
31 | FOXA2 | chr5:69208195-69208910 | A549 | lung: | n/a | n/a |
32 | FOXA2 | chr5:69209004-69209939 | A549 | lung: | n/a | chr5:69209267-69209279 |
33 | FOXP2 | chr5:69207418-69207919 | PFSK-1 | brain: | n/a | n/a |
34 | FOXP2 | chr5:69207189-69207396 | PFSK-1 | brain: | n/a | n/a |
35 | GABPA | chr5:69211916-69212095 | Hela-S3 | cervix: | n/a | n/a |
36 | GABPA | chr5:69211027-69211325 | Hela-S3 | cervix: | n/a | n/a |
37 | GABPA | chr5:69207112-69207357 | Hela-S3 | cervix: | n/a | n/a |
38 | GABPA | chr5:69208961-69209221 | Hela-S3 | cervix: | n/a | n/a |
39 | GABPA | chr5:69211048-69211167 | Hela-S3 | cervix: | n/a | n/a |
40 | GABPA | chr5:69201895-69202109 | Hela-S3 | cervix: | n/a | n/a |
41 | GATA2 | chr5:69205979-69206344 | K562 | blood: | n/a | n/a |
42 | GATA2 | chr5:69209222-69209462 | K562 | blood: | n/a | chr5:69209324-69209334 |
43 | GATA2 | chr5:69203049-69203674 | K562 | blood: | n/a | n/a |
44 | GATA2 | chr5:69211060-69211337 | K562 | blood: | n/a | n/a |
45 | GATA2 | chr5:69202697-69202983 | K562 | blood: | n/a | n/a |
46 | GATA2 | chr5:69204552-69204896 | K562 | blood: | n/a | n/a |
47 | GATA2 | chr5:69204046-69204373 | K562 | blood: | n/a | n/a |
48 | GATA2 | chr5:69201895-69202206 | K562 | blood: | n/a | n/a |
49 | HEY1 | chr5:69210521-69210772 | HepG2 | liver: | n/a | n/a |
50 | HEY1 | chr5:69209001-69209405 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251158 | TF binding region |
ENSG00000198237 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112765880 | chr5:69200796-69200797 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs112423603 | chr5:69201585-69201586 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs370769774 | chr5:69202292-69202293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs375689213 | chr5:69202330-69202331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367618672 | chr5:69202561-69202562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551308368 | chr5:69202593-69202594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368591660 | chr5:69203239-69203240 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs371369818 | chr5:69203688-69203689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62374345 | chr5:69203768-69203769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374685352 | chr5:69203812-69203813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368043700 | chr5:69203889-69203890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62374346 | chr5:69203903-69203904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537020605 | chr5:69204286-69204287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs28409639 | chr5:69206078-69206079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563156921 | chr5:69206546-69206547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530258271 | chr5:69206547-69206548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199599183 | chr5:69206558-69206559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200509451 | chr5:69206564-69206565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62374347 | chr5:69206565-69206566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79855891 | chr5:69206569-69206570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs80196545 | chr5:69206573-69206574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375925859 | chr5:69206624-69206625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62374348 | chr5:69207947-69207948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566891347 | chr5:69209198-69209199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111876451 | chr5:69209537-69209538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368996521 | chr5:69209562-69209563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142445162 | chr5:69209576-69209577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373090490 | chr5:69209739-69209740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376806514 | chr5:69209796-69209797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200196223 | chr5:69209830-69209831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369795330 | chr5:69210014-69210015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs62374349 | chr5:69210362-69210363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs891826 | chr5:69210586-69210587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs833569 | chr5:69210743-69210744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201136499 | chr5:69212288-69212289 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs62374350 | chr5:69212720-69212721 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:69202000-69211400 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
2 | chr5:69208600-69211000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr5:69208600-69211000 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
4 | chr5:69208600-69211000 | Weak transcription | Thymus | Thymus |
5 | chr5:69209800-69210000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr5:69209800-69210000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |